"Sarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
| Descriptor ID |
D012509
|
| MeSH Number(s) |
C04.557.450.795
|
| Concept/Terms |
Sarcoma- Sarcoma
- Sarcomas
- Sarcoma, Soft Tissue
- Sarcomas, Soft Tissue
- Soft Tissue Sarcoma
- Soft Tissue Sarcomas
Sarcoma, Epithelioid- Sarcoma, Epithelioid
- Epithelioid Sarcoma
- Epithelioid Sarcomas
- Sarcomas, Epithelioid
Sarcoma, Spindle Cell- Sarcoma, Spindle Cell
- Sarcomas, Spindle Cell
- Spindle Cell Sarcoma
- Spindle Cell Sarcomas
|
Below are MeSH descriptors whose meaning is more general than "Sarcoma".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma".
This graph shows the total number of publications written about "Sarcoma" by people in this website by year, and whether "Sarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 5 | 1 | 6 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 1 | 4 |
| 2009 | 6 | 1 | 7 |
| 2010 | 2 | 0 | 2 |
| 2011 | 11 | 0 | 11 |
| 2012 | 5 | 2 | 7 |
| 2013 | 7 | 1 | 8 |
| 2014 | 9 | 0 | 9 |
| 2015 | 5 | 0 | 5 |
| 2016 | 4 | 0 | 4 |
| 2017 | 7 | 1 | 8 |
| 2018 | 6 | 1 | 7 |
| 2019 | 7 | 0 | 7 |
| 2020 | 2 | 1 | 3 |
| 2021 | 3 | 1 | 4 |
| 2022 | 10 | 0 | 10 |
| 2023 | 7 | 0 | 7 |
| 2024 | 5 | 1 | 6 |
| 2025 | 5 | 1 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcoma" by people in Profiles.
-
Oncogenic NRAS Mutation in Incipient Sarcomatous Transformation of Cystic Nephroma From a Patient With DICER1-Related Tumor Predisposition Syndrome. Pediatr Blood Cancer. 2026 Feb; 73(2):e70068.
-
Current state of diagnostic genetic testing in pediatric sarcoma: Survey and review by the Cancer Genomics Consortium Sarcoma Working Group. Cancer Genet. 2025 Nov; 298-299:242-255.
-
Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas. Cancer Immunol Res. 2025 Oct 01; 13(10):1591-1608.
-
The International Soft Tissue Sarcoma Consortium: The baseline analysis of rhabdomyosarcoma data. Cancer. 2025 Jul 15; 131(14):e35974.
-
Late Recurrence of Spindle Cell Sarcoma in Association with TPM3::NTRK1 Fusion. Int J Surg Pathol. 2025 Dec; 33(8):1709-1712.
-
Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas: A Consensus Opinion From the Children's Oncology Group, European paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe. Pediatr Blood Cancer. 2025 Apr; 72(4):e31538.
-
Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial. Pediatr Blood Cancer. 2025 Feb; 72(2):e31436.
-
Outcomes for Patients With Head and Neck Sarcoma Treated Curatively With Radiation Therapy and Surgery. Pract Radiat Oncol. 2024 Sep-Oct; 14(5):e373-e382.
-
Imaging Features of Primary Intracranial Sarcoma with DICER1 Mutation: A Multicenter Case Series. AJNR Am J Neuroradiol. 2024 05 09; 45(5):626-631.
-
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial. Nat Cancer. 2024 06; 5(6):880-894.